Efficacy and cost-effectiveness of oral ciprofloxacin.
Barriere
S L
SL
UCLA Medical Center, Los Angeles, California.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics; D002939:Ciprofloxacin / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D016896:Treatment Outcome